연구성과로 돌아가기

2023 연구자 정보 (46 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Chae, Y. K.
(Chae, YK) ⓘ 		Northwestern Univ, Feinberg Sch Med, Chicago, IL USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Incidence and Survival Outcomes of Lung Cancer Post-Double Lung Transplant and its Association with Graft Rejection
[JCR상위 1.5] Concordance Between Generative AI GPT-4 and NCCN Guidelines: Biomarker-Driven Treatment Strategies in NSCLC ⓘ 		SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Choi, C. M.
(Choi, CM) ⓘ 		Univ Ulsan, Coll Med, Asan Med Cenc, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Choi, Chul Won
(Choi, CW) ⓘ 		Korea Univ, Med Ctr, Dept Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Choi, Eun-Ji
(Choi, EJ) ⓘ 		Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Choi, Hyukjin
(Choi, H) ⓘ 		Kyungpook Natl Univ Hosp, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Multicenter, Prospective Study to Investigate the Efficacy and Safety of IntravenousImmunoglobulin Therapy in Elderly Patients with Diffuse Large B Cell Lymphoma Treated with R-Mini-CHOP ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Choi, J.
(Choi, J) ⓘ 		Univ Ulsan, Coll Med, Asan Med Cenc, Seoul, South Korea
Korea Univ, Coll Med, Guro Hosp, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Choi, Juwhan
(Choi, J) ⓘ 		Korea Univ, Guro Hosp, Dept Internal Med, Coll Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data ⓘ 		SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ droij@jnu.ac.kr;
jangtw22@hanmail.net; ⓘ
Choi, Kyomin
(Choi, K) ⓘ 		Konkuk Univ, Dept Neurol, Sch Med, Seoul, South Korea
Konkuk Univ, Sch Med, Dept Neurol, Seoul, South Korea
Konkuk Univ, Sch Med, Dept Neurol, Med Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES
CLINICAL NEUROLOGY ⓘ 		bjkim@skku.edu;sueh916@gmail.com;
paddy.waters@ndcn.ox.ac.uk;nrhong@gmail.com; ⓘ
Choi, S. H.
(Choi, SH) ⓘ 		Kyungpook Natl Univ, Chilgok Hosp, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Comparison of etoposide/cisplatin and irinotecan/cisplatin for extensive-stage small cell lung cancer in Koreans: A real-world retrospective observational study
[JCR상위 1.2] The efficacy and safety of radiation-free retrograde intrarenal surgery: A prospective multicenter-based randomized controlled study ⓘ 		SCIE ⓘ 1.2 ONCOLOGY;RESPIRATORY SYSTEM
UROLOGY & NEPHROLOGY ⓘ 		ⓘ
Choi, Y. -L.
(Choi, YL) ⓘ 		Samsung Med Ctr, Seoul, South Korea
Sungkyunkwan Univ, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Choi, Yunsuk
(Choi, Y) ⓘ 		Univ Ulsan, Dept Hematol, Asan Med Ctr, Coll Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Chung, L. I. -Y.
(Chung, LIY) ⓘ 		Northwestern Univ, Feinberg Sch Med, Chicago, IL USA ⓘ IQU-0821-2023
Chung, Liam Il-Young ⓘ
ⓘ 		[JCR상위 1.5] Incidence and Survival Outcomes of Lung Cancer Post-Double Lung Transplant and its Association with Graft Rejection ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Daver, Naval
(Daver, N) ⓘ 		제1저자 Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA ⓘ AFU-9643-2022
Daver, Naval ⓘ
ⓘ 		[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Fathi, Amir T.
(Fathi, AT) ⓘ 		Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Granados-Lieberman, David
(Granados-Lieberman, D) ⓘ 		Natl Technol Inst Mexico, Irapuato 36821, Gto, Mexico ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Experimental and numerical investigation on a solar-driven torrefaction reactor using woody waste (Ashe Juniper) ⓘ SCIE ⓘ 1.5 ENERGY & FUELS;MECHANICS;THERMODYNAMICS ⓘ namhs219@knu.ac.kr; ⓘ
페이지 이동: